Any thoughts on the future of the B&S division?

[Anonymous]

Seems like a a lot of spend with little reward.

 

[Anonymous]

Seems like a a lot of spend with little reward.

What's B&S????

 

[Anonymous]

you talking about Biologics and Spine?

 

[Anonymous]

Seems like a a lot of spend with little reward.

How much did they earn in 2010 and how much did they spend? Seems odd that they spun away from Memphis.

 

[Anonymous]

That's a bad sign. No one seems to know what the B&S division is.

Of course it is the B&S division to which I am referring.

 

[Anonymous]

That's a bad sign. No one seems to know what the B&S division is.

Of course it is the B&S division to which I am referring.

Meaning Biologics & Spine. I don't believe there are any other S&N division with the initials B&S. Should I also define S&N?

 

[Anonymous]

so it's not Biologics and Spine, you are referring to?

 

[Anonymous]

ha! Yes, please define S&N!
BS is hardly on the radar. You just never hear it mentioned.

 

[Anonymous]

wait- are we talking about Biologics and Spine here? I'm not following you people

 

[Anonymous]

Didn't know we had any biologic products or Spine products. (thought we sold spine off)
Are you referring to the Clinical Therapies division?

 

[Anonymous]

Didn't know we had any biologic products or Spine products. (thought we sold spine off)
Are you referring to the Clinical Therapies division?

i agree, i thought we sold off spine...maybe the OP just crawled out of his/her cave. what the hell u talking bout willis???

 

[Anonymous]

Distributors.

 

[Anonymous]

Confirms my suspicions. No one knows about the Biologics & Spine division. There really isn't a Clinical Therapies division although we still use the term.

First, when we set up the B&S division on paper everyone hopped on the bandwagon. Now that we realize we can't play in the same sandbox with big pharma everyone is scrambling back to Clinical Therapies which doesn't even exist.

Funny we started a Biologics & Spine division then immediately sold off all of our spine products which Marky Mark brought over just 3 years ago from Endo. Brilliant.

Now we have no products but around 100 employees on the payroll including 14 VPs, 10 directors and 5 managers. I thought the tip of the org chart is supposed to be pointing up.

 

[Anonymous]

You must be the only one who knows of a "B&S Division" at SN.

 

[Anonymous]

Confirms my suspicions. No one knows about the Biologics & Spine division. There really isn't a Clinical Therapies division although we still use the term.

First, when we set up the B&S division on paper everyone hopped on the bandwagon. Now that we realize we can't play in the same sandbox with big pharma everyone is scrambling back to Clinical Therapies which doesn't even exist.

Funny we started a Biologics & Spine division then immediately sold off all of our spine products which Marky Mark brought over just 3 years ago from Endo. Brilliant.

Now we have no products but around 100 employees on the payroll including 14 VPs, 10 directors and 5 managers. I thought the tip of the org chart is supposed to be pointing up.

What the heck are you talking about? The clinical therapies division or BS, (whatever they are calling themselves this week) has more employees than 100.